BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

Search

Merck KGaA

Închisă

121.4 1.42

Rezumat

Modificarea prețului

24h

Curent

Minim

119.7

Maxim

122.55

Indicatori cheie

By Trading Economics

Venit

-142M

667M

Vânzări

152M

5.4B

P/E

Medie Sector

26.27

57.333

EPS

2.2

Randament dividend

1.34

Marjă de profit

12.311

EBITDA

85M

1.6B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+38.83% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.34%

2.63%

Următoarele câștiguri

15 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

33B

98B

Deschiderea anterioară

119.98

Închiderea anterioară

121.4

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

Merck KGaA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 mar. 2025, 06:27 UTC

Câștiguri

Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results

11 feb. 2025, 07:03 UTC

Achiziții, Fuziuni, Preluări

Germany's Merck in Talks to Buy SpringWorks Therapeutics

10 feb. 2025, 16:38 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

SpringWorks Therapeutics Shares Rise on Report it May be Acquired

24 apr. 2025, 22:51 UTC

Top știri
Achiziții, Fuziuni, Preluări

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update

24 apr. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Merck KGaA: No Final Decision Has Been Taken; No Legally Binding Agreement Has Been Entered Into

24 apr. 2025, 20:50 UTC

Achiziții, Fuziuni, Preluări

Merck KGaA Confirms Late-Stage Discussions With SpringWorks Therapeutics on Potential Acquisition for About 47c a Share

24 apr. 2025, 19:05 UTC

Achiziții, Fuziuni, Preluări

Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks, Sources Say -- WSJ

24 apr. 2025, 19:05 UTC

Achiziții, Fuziuni, Preluări

Merck KGaA, SpringWorks Deal Expected to Be Finalized as Soon as Monday, Sources Say -- WSJ

24 apr. 2025, 19:05 UTC

Top știri
Achiziții, Fuziuni, Preluări

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- WSJ

24 apr. 2025, 19:05 UTC

Achiziții, Fuziuni, Preluări

Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ

6 mar. 2025, 11:18 UTC

Market Talk
Câștiguri

Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk

6 mar. 2025, 11:14 UTC

Market Talk

Merck KGaA's Outlook Signals Greater Transparency -- Market Talk

6 mar. 2025, 08:20 UTC

Market Talk
Câștiguri

Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA 2024 Adj EPS EUR8.63

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA 2024 EBIT EUR3.645B

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA 2024 After-Tax Profit EUR2.79B

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA 2024 EBITDA EUR5.78B

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA 2024 Sales EUR21.16B

6 mar. 2025, 06:00 UTC

Câștiguri

Merck KGaA Keeps Dividend at EUR2.20

6 mar. 2025, 06:00 UTC

Câștiguri

Analysts Saw Merck KGaA 2024 Sales at EUR21.14B

6 mar. 2025, 06:00 UTC

Câștiguri

Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B

11 feb. 2025, 16:45 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk

11 feb. 2025, 10:54 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk

11 feb. 2025, 10:52 UTC

Market Talk
Achiziții, Fuziuni, Preluări

German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk

6 ian. 2025, 13:08 UTC

Achiziții, Fuziuni, Preluări

Merck KGaA: Transaction closed on Dec. 23, 2024

6 ian. 2025, 13:07 UTC

Achiziții, Fuziuni, Preluări

Merck KGaA: Didn't Disclose Financial Details

6 ian. 2025, 13:06 UTC

Achiziții, Fuziuni, Preluări

Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio

Comparație

Modificare preț

Merck KGaA Așteptări

Obiectiv de preț

By TipRanks

38.83% sus

Prognoză pe 12 luni

Medie 166.25 EUR  38.83%

Maxim 190 EUR

Minim 107 EUR

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMerck KGaA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

9 ratings

6

Cumpărare

2

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

117.55 / 120.4Suport & Rezistență

Termen scurt

Very Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Merck KGaA

There is no Profile data available for MRK.BE.